Cargando…
Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110673/ https://www.ncbi.nlm.nih.gov/pubmed/36571598 http://dx.doi.org/10.1007/s00262-022-03342-x |
| _version_ | 1785027310424948736 |
|---|---|
| author | Qiao, Tianyun Zhao, Jinbo Xin, Xiangbing Xiong, Yanlu Guo, Wenwen Meng, Fancheng Li, Hui Feng, Yangbo Xu, Hui Shi, Changhong Han, Yong |
| author_facet | Qiao, Tianyun Zhao, Jinbo Xin, Xiangbing Xiong, Yanlu Guo, Wenwen Meng, Fancheng Li, Hui Feng, Yangbo Xu, Hui Shi, Changhong Han, Yong |
| author_sort | Qiao, Tianyun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10110673 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101106732023-04-19 Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model Qiao, Tianyun Zhao, Jinbo Xin, Xiangbing Xiong, Yanlu Guo, Wenwen Meng, Fancheng Li, Hui Feng, Yangbo Xu, Hui Shi, Changhong Han, Yong Cancer Immunol Immunother Correction Springer Berlin Heidelberg 2022-12-26 2023 /pmc/articles/PMC10110673/ /pubmed/36571598 http://dx.doi.org/10.1007/s00262-022-03342-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Qiao, Tianyun Zhao, Jinbo Xin, Xiangbing Xiong, Yanlu Guo, Wenwen Meng, Fancheng Li, Hui Feng, Yangbo Xu, Hui Shi, Changhong Han, Yong Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model |
| title | Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model |
| title_full | Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model |
| title_fullStr | Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model |
| title_full_unstemmed | Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model |
| title_short | Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model |
| title_sort | correction to: combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110673/ https://www.ncbi.nlm.nih.gov/pubmed/36571598 http://dx.doi.org/10.1007/s00262-022-03342-x |
| work_keys_str_mv | AT qiaotianyun correctiontocombinedpembrolizumabandbevacizumabtherapyeffectivelyinhibitsnonsmallcelllungcancergrowthandpreventspostoperativerecurrenceandmetastasisinhumanizedmousemodel AT zhaojinbo correctiontocombinedpembrolizumabandbevacizumabtherapyeffectivelyinhibitsnonsmallcelllungcancergrowthandpreventspostoperativerecurrenceandmetastasisinhumanizedmousemodel AT xinxiangbing correctiontocombinedpembrolizumabandbevacizumabtherapyeffectivelyinhibitsnonsmallcelllungcancergrowthandpreventspostoperativerecurrenceandmetastasisinhumanizedmousemodel AT xiongyanlu correctiontocombinedpembrolizumabandbevacizumabtherapyeffectivelyinhibitsnonsmallcelllungcancergrowthandpreventspostoperativerecurrenceandmetastasisinhumanizedmousemodel AT guowenwen correctiontocombinedpembrolizumabandbevacizumabtherapyeffectivelyinhibitsnonsmallcelllungcancergrowthandpreventspostoperativerecurrenceandmetastasisinhumanizedmousemodel AT mengfancheng correctiontocombinedpembrolizumabandbevacizumabtherapyeffectivelyinhibitsnonsmallcelllungcancergrowthandpreventspostoperativerecurrenceandmetastasisinhumanizedmousemodel AT lihui correctiontocombinedpembrolizumabandbevacizumabtherapyeffectivelyinhibitsnonsmallcelllungcancergrowthandpreventspostoperativerecurrenceandmetastasisinhumanizedmousemodel AT fengyangbo correctiontocombinedpembrolizumabandbevacizumabtherapyeffectivelyinhibitsnonsmallcelllungcancergrowthandpreventspostoperativerecurrenceandmetastasisinhumanizedmousemodel AT xuhui correctiontocombinedpembrolizumabandbevacizumabtherapyeffectivelyinhibitsnonsmallcelllungcancergrowthandpreventspostoperativerecurrenceandmetastasisinhumanizedmousemodel AT shichanghong correctiontocombinedpembrolizumabandbevacizumabtherapyeffectivelyinhibitsnonsmallcelllungcancergrowthandpreventspostoperativerecurrenceandmetastasisinhumanizedmousemodel AT hanyong correctiontocombinedpembrolizumabandbevacizumabtherapyeffectivelyinhibitsnonsmallcelllungcancergrowthandpreventspostoperativerecurrenceandmetastasisinhumanizedmousemodel |